Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧
@carloscaldas1960.bsky.social
Cancer Physician Scientist @caldaslab.bsky.social @hebrewuniversity.bsky.social @lautenbergc.bsky.social @hadassahorg.bsky.social Functional genomics. Breast cancer ecosystems. Cell state and cell fate. Precision Cancer Medicine 2.0 #METABRIC #PDTXs
@hebrewuniversity.bsky.social Computational Medicine [HUCMED] about to start at Yad HaShoma near Jerusalem. @caldaslab.bsky.social present with 2 oral presentations!
@hebrewuniversity.bsky.social Computational Medicine [HUCMED] about to start at Yad HaShoma near Jerusalem. @caldaslab.bsky.social present with 2 oral presentations!
It's the British disease Senior leadership means never having to face the consequences Not just in devastated universities like Nottingham It's everywhere in the UK, the Post Office, NHS, Civil Service Those responsible are never held accountable www.timeshighereducation.com/news/notting...
Nottingham confirms course closures with hundreds of jobs affected
Languages and music departments to close despite strikes and protests but university insists it has addressed staff concerns in revised plans
timeshighereducation.com
Paper @nature.com by @stephensammut.bsky.social reached an incredible 500 citations @clarivate.com WoS! @carloscaldas1960.bsky.social consistently reporting new paradigms! In this case using ML to integrate multi-omics to generate a predictive model of response. www.nature.com/articles/s41...
Multi-omic machine learning predictor of breast cancer therapy response - Nature
Integration of pre-treatment tumour features in predictive models using machine learning could inform on response to therapy.
nature.com
A succinct piece about the flurry of activities that continue to promote MCEDs despite the negative Grail-Galleri trial. "This environment doesn’t lend itself to unbiased decision making." (i.e. panels of experts with serious financial conflicts of interest). www.bmj.com/content/395/...
Galleri: Trial results show why the NHS must not follow the US FDA in approving the multicancer test
After failing to meet the primary endpoint and controversy around lobbying and competing interests, the NHS must take its next steps cautiously, writes Margaret McCartney On 22 September, the New En...
bmj.com
This is IMPORTANT! Pointing out the trial was NEGATIVE. Still the authors could have pointed out two key things: 2- the correct endpoint for cancer screening is OS (not cancer-specific survival!); and 2- stage migration is USELESS. pubmed.ncbi.nlm.nih.gov/42767255/
Multicancer detection tests: holy grail or cautionary tale? - PubMed
Multicancer detection tests: holy grail or cautionary tale?
pubmed.ncbi.nlm.nih.gov
#BirdOfTheDay theme #perched #birds #BirdsOfTheWorld #nature I saw this Clark's nutcracker perched on a limber pine during a hike on Sunday in the high mountains of the San Bernardino range. I was not carry a zoom lens, but the photo was enough for me to identify the species when I got home.
#Caldasians @kylie-gorringe.bsky.social and David Huntsman in Montreal. @caldaslab.bsky.social keeps up with all it's alumni and revels in their success!
Caldasians in Turin for Giulia Lerda's wedding. Fantastic to see former @caldaslab.bsky.social members enjoying each other's company!
I was very pleased to share research from @caldaslab.bsky.social with our colleagues at #Weizmann-Institute! Now based @hebrewuniversity.bsky.social within the @lautenbergc.bsky.social #Caldasians continue to walk the walk!
@adaryaacov.bsky.social with another Merit Award to present: Abstract: #309; A pan cancer foundation-model atlas of regulatory variant function and its prognostic application across 238,000 tumors @caldaslab.bsky.social walks the walk!
This is IMPORTANT! Pointing out the trial was NEGATIVE. Still the authors could have pointed out two key things: 2- the correct endpoint for cancer screening is OS (not cancer-specific survival!); and 2- stage migration is USELESS. pubmed.ncbi.nlm.nih.gov/42767255/
Multicancer detection tests: holy grail or cautionary tale? - PubMed
Multicancer detection tests: holy grail or cautionary tale?
pubmed.ncbi.nlm.nih.gov
Wow!! Congratulations 🎊 👏💐 @adaryaacov.bsky.social! @caldaslab.bsky.social is committed to train outstanding clinicuan-scientists!
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧@carloscaldas1960.bsky.social · 3w ago@adaryaacov.bsky.social just joined @caldaslab.bsky.social! He is already making (good) waves: Oral Presentation and Merit Award from @myesmo.bsky.social to attend ESMO Asia! @caldaslab.bsky.social now @lautenbergc.bsky.social is made of outsanding people! Walking tge walk!
@adaryaacov.bsky.social just joined @caldaslab.bsky.social! He is already making (good) waves: Oral Presentation and Merit Award from @myesmo.bsky.social to attend ESMO Asia! @caldaslab.bsky.social now @lautenbergc.bsky.social is made of outsanding people! Walking tge walk!
Congratulations to @gopaliyer.bsky.social for this well deserved distinction! I am so proud of yet another #Caldasian being honored! @caldaslab.bsky.social has always been made of amazing people! Congratulations 🎊
Honoured to be named one of Canada’s #Top40Under40! Grateful to my mentors, trainees, collaborators, friends and family for their support. Excited to continue advancing #CancerResearch and patient care @uhn.ca @uhnresearch.ca
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧@carloscaldas1960.bsky.social · 4w ago@nguyenlab.bsky.social a top #Caldasian is a top 40 under 40 in Canada! @caldaslab.bsky.social has always been made of stars! I am the luckiest PI and mentor there is! financialpost.com/news/meet-ca...
@nguyenlab.bsky.social a top #Caldasian is a top 40 under 40 in Canada! @caldaslab.bsky.social has always been made of stars! I am the luckiest PI and mentor there is! financialpost.com/news/meet-ca...
Meet Canada's Top 40 Under 40 for 2026
Canada’s Top 40 Under 40 is back after a four year hiatus. Here is the 2026 list of honourees. Find out more.
financialpost.com
Very happy to give a talk at IMRIC retreat! @caldaslab.bsky.social starting to walk the walk @hebrewuniversity.bsky.social!
The first posters from @caldaslab.bsky.social based @lautenbergc.bsky.social. Well done Amal and @joellelahmi.bsky.social! Thank you @osnatha.bsky.social for all your support!
IMRIC retreat in Haifa! @hebrewuniversity.bsky.social biomedical research retreat for 3 days! Looking forward to exciting science!
A must read! Simple yet insightful. Thanks @reisesousalab.bsky.social!
Caetano Reis e Sousa@reisesousalab.bsky.social · 2mo agoHope you enjoy this short piece, which came out yesterday. Some thoughts I’ve been musing on for a while about why adaptive immunity evolved. Read it for free at rdcu.be/fAO5P
@caldaslab.bsky.social gets its first PDTXs growing! Great collaboration with Yoni Arnon @hadassahorg.bsky.social! Thanks to @osnatha.bsky.social for the H&E pictures of this NSCLC model growing in all 7 NSG implanted! We will use these and other PDTX models to study tumor ecosystems.
Get your calendars, because the new 2027 EMBL Annual Poster has arrived: s.embl.org/2027-poster Whether you'd like to enhance your skills in a practical course or engage with the latest research at one of our conferences, we've got you covered. See you at EMBL in 2027! 🙌 #LifeSciences #EMBL
I am present in spirit! #Caldasians geeting together to celebrate the graduation of @allanlui.bsky.social from @caldaslab.bsky.social in Cambridge. Beautiful people from a great lab! #Caldasians now growing @hebrewuniversity.bsky.social! All the same spirit: making discoveries and enjoying life!
@caldaslab.bsky.social now based @lautenbergc.bsky.social @hebrewuniversity.bsky.social lab outing in Tel Aviv.
